Towards Healthcare

NEWS & INSIGHTS

Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.

Axsome receives clearance to NDA filing for AXS-05 and Priority Review designation
Date 06 January 2026

Axsome receives clearance to NDA filing for AXS-05 and Priority Review designation

Announcement Axsome Therapeutics, Inc., a leading biopharmaceutical company revolutionising the treatment space of central nervous system (CNS) disorders, received acceptance from the U.S. Food and D...

XORTX's Research and business update to accelerate growth
Date 06 January 2026

XORTX's Research and business update to accelerate growth

Announcement XORTX Therapeutics Inc., a leading late-stage clinical pharmaceutical company aiming to establish innovative therapies for the treatment of progressive kidney and gout diseases, unveiled...

Cogent enveloped its application to the FDA
Date 05 January 2026

Cogent enveloped its application to the FDA

Announcement Cogent Biosciences, Inc., a leading biotechnology company dedicated to establishing accurate therapies for genetically defined diseases, has now submitted its promising New Drug Applicat...

SELLAS informed of an update of its Phase 3 REGAL trial
Date 01 January 2026

SELLAS informed of an update of its Phase 3 REGAL trial

Announcement SELLAS Life Sciences Group, Inc., a leading late-stage clinical biopharmaceutical company focused on the establishment of novel therapies for a wide range of cancer indications have an u...

Caliway cleared one stage of its Phase 2 Clinical Study in Weight Management
Date 31 December 2025

Caliway cleared one stage of its Phase 2 Clinical Study in Weight Management

Announcement Caliway, a leading biopharmaceutical company, proudly announced its submission of an Investigational New Drug (IND) application to the US FDA for its robust Phase 2 clinical study of its...

Nona Biosciences extensional initiative for early clinical development and IITs
Date 30 December 2025

Nona Biosciences extensional initiative for early clinical development and IITs

Announcement Nona Biosciences, a leading biotechnology company thoroughly modernising the discovery pathway via innovative technology platforms have now extended its unified development and explorato...

Mabwell received thumbs up from the IND for its clinical study based on COPD
Date 30 December 2025

Mabwell received thumbs up from the IND for its clinical study based on COPD

Announcement Mabwell, a leading innovation enthusiast biopharmaceutical company with a fully unified industry chain, has declared that it has received clearance from the U.S. Food and Drug Administra...

China's NMPA approval for domestic injectables to make headlines in the healthcare market
Date 30 December 2025

China's NMPA approval for domestic injectables to make headlines in the healthcare market

Announcement The China-based Innovent Biologics, Inc., a leading biopharmaceutical company that focuses on establishing, manufacturing, and marketing quality-standard medicines for curing autoimmune,...

IRLAB received the official stamp on its Phase IB Study
Date 29 December 2025

IRLAB received the official stamp on its Phase IB Study

Announcement IRLAB Therapeutics AB, a leading company aimed on developing and exploring new treatments for Parkinson’s disease, announced that it has received a green signal for its Phase IB st...

Next Gen's NGD Infection Prevention to come into force from 1st January 2026
Date 29 December 2025

Next Gen's NGD Infection Prevention to come into force from 1st January 2026

Announcement Next Gen Diagnostics announced the exciting offshoot of its Infection Prevention division into an independent and strong-headed company from 1st January 2026. The company will be called ...

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.